Randall Stuewe
Analyst · Goldman Sachs
Thanks, Melissa. Good morning, everyone and thank you for joining us today. As we discussed in our last call, we anticipated some seasonal tempering of core business earnings after a strong Q2. Seasonal softening, alongside production and market adjustments within our gelatin business, account for the majority of this decline. Our DGD investment performed exceptionally well once again, providing a counter hedge to lower prices of fats and greases. All in all, we're carrying good momentum into fourth quarter and into the coming year. Now let's look at the segments. In the Food segment on a sequential basis our performance dropped sharply, attributable primarily to Rousselot, our gelatin business. During the quarter, China and U.S.A plants took major annual turnarounds for maintenance, we had a temporary production interruption at our Angouleme, France, plant and demand declines for low-bloom gelatin in China drove an inventory write-down charge. Interestingly enough, I must point out that, year over year, we're only down modestly in the quarter. And this is predominantly related to the inventory write-down charge. In the Feed segment, results sequentially softened, but held up nicely considering volatile and sharply declining fat prices. European and Canadian rendering margins held solidly, while the U.S.A chased the declining values of fats and greases in their formulas. Fat prices continue to be resilient, supported by world demand, as India and China consume more along with growing global biodemand. Protein prices for the quarter were steady, but late in September the pressures of the largest harvest on record began to weigh on values. Raw material volumes were strong around the globe. And this continues to put abundant protein supplies on the market. Our global blood business came in slightly lower but remained strong in China, as demand for plasma for piglet feed continues to be robust, along with strong hemoglobin demand in the aqua culture sector. Our restaurant services business in the U.S.A continues to enjoy tonnage growth. Our improved go-to-market strategy for this unit continues to show promise and should pay nice dividends in our Fuels business, as this is the preferred feedstock from a carbon intensity standpoint. The U.S.A bakery feeds business tonnage is up year over year. And through prudent and smart risk management, earnings have improved in light of lower corn prices. Additionally our premium proteins group which includes pet food blending, wet pet food and fertilizer, all delivered consistent results. Our new wet pet food plants turned the corner and should be contributing at expected rates by the end of the year. Finally, our Fuel segment turned in a steady performance during a normally light seasonality. Tonnage shipped to Rendac, our European-based waste energy business and Ecoson, our Euro-based digesting and refining business, were sequentially lower, thus third quarter earnings declined slightly. However, improved volumes and solid operating performance contributed to year-over-year increases. Our Canadian biodiesel profitability came in slightly less sequentially but delivered on target and ahead of last year. Operating at capacity, Diamond Green Diesel demonstrated outstanding earnings power and reported its strongest earnings contribution to date, improving EBITDA by 23% from the previous quarter. Our model once again proved viable by capitalizing on lower fat prices in the quarter, arbitraged into higher earnings at Diamond Green Diesel. We also loaded a RIN-less vessel shipment on the last day of the month. RINs are marked to zero until they are sold. Therefore we anticipate roughly $9 million of earnings will shift into Q4. As I mentioned earlier, most of our products are now moving to the LCFS markets. And we expect a strong Q4. Building on this momentum, we expect solid margins heading into 2017. On the DGD expansion front, final engineering is complete which at full capacity will increase our annual production from 160 million gallons to 275 million gallons. We made modifications to allow for additional flexibility on raw materials and product shipping that creep the scope and the cost of the facility. Our final cost estimate is $190 million. And construction is now scheduled to be completed and start up in early second quarter 2018. We remain net debt free in the joint venture. And our obligation to our partner is to retain the cash necessary to fund the extension. All said, no matter what your view is on the tax credit extension, we will be debt free in early 2018. And we will then have the freedom and opportunity to issue dividends, as prudent. Looking ahead, we expect the fourth quarter to deliver another strong DGD performance. Rousselot should also rebound. And the rendering business will continue to make adjustments to manage the volatile pricing environment due to the globally ample crops and continuing strong animal slaughter. All of our new assets are up and performing nicely. And we've commenced construction of two additional plants, one in Mering, Germany, for blood and a new digester in Denderleeuw, Belgium. As John will outline further, we will continue to strengthen our balance sheet and are well on our way to our $150 million debt reduction target for 2016. Our leverage ratio has now broken the 4 market. And additionally we continue to improve working capital usage while deploying capital to grow and maintain our world-class infrastructure. So with that, I'll let John take you through some financial highlights and I'll come back with a few closing comments. John?